India Hits 200 Crore Vaccination Milestone

India achieved the historic milestone of the 200 crore mark in Covid-19 vaccination. Milestone was reached after 18 months when India began mass vaccination.

India achieved the historic milestone of the 200 crore mark in COVID-19 vaccination. The milestone was reached after 18 months when the nation began the mass vaccination on January 16, 2021.

On January 16, 2021, two Made-in-India vaccines -- Covaxin and Covishield -- were made available for Indian citizens. After nine months, India completed the first 100 crore vaccination mark on October 21, 2021. The nation has completed 200 crore mark again after another nine months on July 17, 2022.

Omicron Variant of COVID-19
Omicron variant is a mutated strain of coronavirus (SARS-CoV-2) with faster transmissibility and enhanced virulence compared to the original COVID-19 virus.

‘According to the Co-Win Portal, with a total 1.91 lakhs of vaccine being administered so far on Sunday, the number crossed the milestone mark of 200 crore. A total of 199.97 crore Covid vaccine doses were administered across the country until Saturday night, which includes 5.48 crore doses of the precaution dose.’

It took 277 days to reach the earlier milestone of 100 crore doses. On September 17 last year, the highest 2.5 crore vaccine doses were administered in a single day.

COVID Vaccination In India

Congratulating the nation on this historic mark, Union Health Minister Mansukh Mandaviya said that India has made a new record. "India has set a new record by completing the target of 200 crore vaccinations in just 18 months. Hearty congratulations to all the countrymen on this achievement", said Mandaviya in a tweet. He said that this day is to be remembered forever.

Dr Poonam Khetrapal Singh, Regional Director WHO South-East Asia, also congratulated India on administering 2 billion COVID-19 vaccine doses.

"Congratulations India for administering over 2 billion COVID-19 vaccine doses. This is yet another evidence of the country’s commitment and efforts to minimise the impact of the ongoing pandemic. COVID-19 vaccines provide protection against severe disease and death for all variants. We must continue our efforts to ensure everyone everywhere benefits from these life-saving vaccines. Let us not forget that the pandemic is still around even after taking the vaccine we must remember to take all precautionary measures to curtail the virus spread," Dr Poonam Khetrapal Singh said.

Test your Knowledge on Coronavirus (COVID-19)
Coronavirus is a large positive-strand RNA virus that is surrounded by a protein envelope. The virus obtains its name from the S protein spikes on its surface, which resemble a crown. The overall pattern of increasing coronavirus cases is shown to spike up with the “second wave” of COVID-19.

With spiking effects of the second wave of coronavirus, the best way to keep it at bay is to follow COVID-appropriate safety practices like wearing a mask, regularly cleaning your hands, and coughing into a bent elbow or tissue along with physical distancing (6 feet about 2 arm's length), that may help evade the severity of COVID-19 infection.

India’s first patient infected with COVID virus was reported in Thrissur District of Kerala on January 30, 2020. However, the global health body World Health Organisation also declared COVID outbreak as a Public Health Emergency of International Concern (PHEIC) on January 30, 2020. Later on, March 11, 2020, the WHO declared the coronavirus outbreak as a pandemic.

Source-IANS

COVID-19 in India: 20,038 New Covid Cases, 47 Deaths
In the last 24 hours, India has reported a marginal decline at 20,038 Covid infections against 20,139 cases reported on Thursday, the Union Health Ministry said.

Can Frequent Rapid-antigen Testing Keep People Safe from COVID-19?
Regular testing lowers the risk of Covid-19 infection and can reduce extended transmissions within groups.